Filing step-change
EPBIO · 2026-09
Quarterly observations that moved versus the prior period in 2026-09. Facts only — not a call to act.
Narrative date 2026-09-29 · Evidence medium
Epic Bio (EPBIO) Sees Standard Shift in Key Metrics Epic Bio (EPBIO) experienced a standard shift in its key metrics, with notable improvements in gross margin and marginal operating leverage.
Raw Evidence
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 36.28 % | 20.39 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 20.39 % | 10.69 | ▲ |
| REVENUE_GROWTH_YOY | 25.8 % | 64.7 | ▼ |
Cite this
Source: Samhati filing step-change for EPBIO (2026-09). Observation: Epic Bio (EPBIO) Sees Standard Shift in Key Metrics Epic Bio (EPBIO) experienced a standard shift in its key metrics, with notable improvements in gross margin and marginal operating leverage. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/epbio/q/2026-09
Other periods